brief hx: liver nodule
this study has been compared to the previous study at 20190110
ct of liver without and with iv enhancement triphasic scans studies  
techniques: 
from lower chest to liver inferior edge in 5-mm contiguous section, contrast 
medium injected, arterial phase scan starting at 30 sec after initiation of 
injection; portal phase scan performed in 20 sec after the end of the arterial 
phase; and venous phase scan at 20 sec after the end of the portal phase 

findings:
no definite pulmonary nodule in visible lung field.
calcification of coronary artery at risk of coronary artery disease. 
relative low density of liver is compatible with fatty liver 
stable early enhance liver nodule about 2.7cm in s7 with early washout at late 
phase, worrisome for hcc.
another early enhancing and early washout nodule in the s4 liver, 0.7 cm, also 
hcc?
patency of the portal veins
gallstone without apparent inflammatory change of gb 
mild splenomegaly
no ascites
no definite biliary dilatation, normal gb
unremarkable change of the pancreas
no abnormal fluid collection in the abdomen 
no hydronephrosis
no evident enlarged retroperitoneal lns
no dilated appendix. 
degenerative change of lumbar spine with spurs formation 

imp:
1. stable early enhance liver nodule about 2.7cm in s7 with early washout at 
late phase, worrisome for hcc.
2. another early enhancing and early washout nodule in the s4 liver, 0.7 cm, 
also hcc?

revised report for staging
¡´imaging report form for hepatocellua carcinoma (ajcc 8th edition)
1.tumor number/location: 
number: ¡´1 ¡³2 ¡³3 multiple:
location: s7 
2.tumor size: 
    ¡´measurable: 2.7 cm (the largest tumor)
    ¡³non-measurable
3.tumor characteristics and associated liver features
    ¡³vascular invasion 
    ¡³extrahepatic spread 
    ¡³ascites 
    ¡³portal vein thrombosis, location 
    ¡³portosystemic collateral vessel
    ¡³typical enhancement pattern (hypervascular enhancement and early wash-out)
3.pathology: ¡³not available ¡´available (pathology type:hcc)

-------------------primary tumor(t)--------------------------
 tx  ¡³ primary tumor cannot be assessed 
 t0  ¡³ no primary tumor 
stage i
t1   ¡´ solitary tumor ¡Ø2 cm, or > 2cm without vascular invasion
t1a  solitary tumor ¡Ø2 cm
t1b  solitary tumor > 2cm without vascular invasion
stage ii
t2   ¡³ solitary tumor >2cm with vascular invasion, or multiple tumors,none >5
cm 
stage iii
t3   ¡³multiple tumors more than 5 cm 
t4   ¡³tsingle tumor or multiple tumors of any size involving a major
branch of the portal vein or hepatic vein, or tumor(s) with direct
invasion of adjacent organs other than the gallbladder or with
perforation of visceral peritoneum 
-------------------regional lymph nodes(n)-----------------
nx   ¡³regional lymph nodes cannot be assessed 
n0   ¡³no regional lymph nodes
stage iva
n1   ¡³regional lymph node metastasis 
     ¡³periceliac, ¡³hilar( common bile duct, hepatic artery, portal vein and 
cystic duct) ¡³peripancreatic ¡³paraaortic ¡³portocaval ¡³retrocaval
¡³others_______ 
-------------------distant metastasis(m)----------------------
stage ivb
m1  ¡³distant metastasis
¡³	invasion of gallbladder
¡³	cardiophrenic, mesenteric, retrocrural ln
imaging stage   t1b n0 ( in this study)